Share via:
PharmEasy-owned diagnostics platform Thyrocare’s consolidated net profit zoomed 25.6% to INR 21.6 Cr in the fourth quarter of the financial year ended March 2025 (Q4 FY25) from INR 17.2 Cr in the year-ago quarter.
Sequentially, profit increased 14% from INR 18.95 Cr.
Meanwhile, the company’s consolidated operating revenue grew 21.3% to INR 187.2 Cr during the quarter under review from INR 154.3 Cr in Q4 FY24. The topline rose 12.8% quarter-on-quarter (QoQ) from INR 165.9 Cr.
Thyrocare’s…
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
PharmEasy-owned diagnostics platform Thyrocare’s consolidated net profit zoomed 25.6% to INR 21.6 Cr in the fourth quarter of the financial year ended March 2025 (Q4 FY25) from INR 17.2 Cr in the year-ago quarter.
Sequentially, profit increased 14% from INR 18.95 Cr.
Meanwhile, the company’s consolidated operating revenue grew 21.3% to INR 187.2 Cr during the quarter under review from INR 154.3 Cr in Q4 FY24. The topline rose 12.8% quarter-on-quarter (QoQ) from INR 165.9 Cr.
Thyrocare’s…
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi
